معلومات عن هذه الحلقة

الإنجليزية
أستراليا

وتظهر الملاحظات 🔗

النص 🔗

البحث في الحلقات الماضية

البحث في الحلقات السابقة من ASX BRIEFS.

حلقات أخرى في هذا البودكاست

Send us Fan Mail ASX Investment Opportunity - Alchemy Resources Ltd (ASX:ALY)A junior explorer can’t do everything at once, so the smart ones pick their shots, partner early, and protect the balance sheet while they drill. That’s what we dig into with James Wilson, CEO of Alchemy Resources Limited,…
Send us Fan Mail ASX Investment Opportunity - Change Financial Ltd (ASX:CCA)Profit doesn’t arrive overnight in fintech, especially when you’re building the core infrastructure that other brands depend on. We’re joined by Tony Sheehan, CEO of Change Financial Limited, to break down the FY26 result a…
Send us Fan Mail ASX Investment Opportunity - GALE Pacific Ltd (ASX:GAP)Revenue drops, yet EBITDA rises and the balance sheet flips to net cash. That’s the tension at the heart of our chat with Troy Mortleman, CEO of GALE Pacific Limited, the ASX-listed manufacturer behind innovative shade fabrics …
Send us Fan Mail ASX Investment Opportunity - AML3D Ltd (ASX:AL3)A metal part fails on a ship, the clock starts ticking, and the supply chain suddenly matters more than the design. That’s the lens we bring to our chat with Sean Ebert, Managing Director and CEO of AML3D Limited, as we unpack how ind…
Send us Fan Mail A cancer therapy discovered through Australian nature sounds like folklore until you hear the data and the strategy behind it. Andrew is joined by Ebru Davidson, interim CEO and Managing Director of QBiotics Limited, to unpack how an unlisted Brisbane biotech is building “partner-r…
إخلاء المسؤولية: البودكاست والأعمال الفنية المضمنة في هذه الصفحة مأخوذة من Andrew Musgrave، وهي مملوكة لمالكها وليست تابعة لشركة Listen Notes, Inc أو معتمدة منها.